Phase 3 CheckMate 067 trial of nivolumab in untreated advanced melanoma | Dr Tobias-Hendrik Arkenau at ASCO 2015

Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute, UK, disusses the results of the CheckMate 067 trial, a phase 3 trial of nivolumab (NIVO) alone or combined with ipilimumab (IPI) ve... Author: EMJ Added: 07/17/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts